Strategic Financial Concepts LLC Purchases Shares of 12,422 Silicon Laboratories Inc. (NASDAQ:SLAB)

Strategic Financial Concepts LLC bought a new position in shares of Silicon Laboratories Inc. (NASDAQ:SLAB - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 12,422 shares of the semiconductor company's stock, valued at approximately $1,543,000.

Several other large investors have also bought and sold shares of SLAB. Advisors Asset Management Inc. grew its holdings in Silicon Laboratories by 159.4% during the 3rd quarter. Advisors Asset Management Inc. now owns 275 shares of the semiconductor company's stock worth $32,000 after acquiring an additional 169 shares during the period. GAMMA Investing LLC grew its holdings in Silicon Laboratories by 84.1% during the 3rd quarter. GAMMA Investing LLC now owns 497 shares of the semiconductor company's stock worth $57,000 after acquiring an additional 227 shares during the period. International Assets Investment Management LLC grew its holdings in Silicon Laboratories by 11,457.1% during the 3rd quarter. International Assets Investment Management LLC now owns 809 shares of the semiconductor company's stock worth $93,000 after acquiring an additional 802 shares during the period. KBC Group NV grew its holdings in Silicon Laboratories by 42.1% during the 4th quarter. KBC Group NV now owns 1,279 shares of the semiconductor company's stock worth $159,000 after acquiring an additional 379 shares during the period. Finally, Van ECK Associates Corp acquired a new stake in Silicon Laboratories during the 3rd quarter worth about $189,000.

Analysts Set New Price Targets

A number of analysts have weighed in on the company. Susquehanna assumed coverage on Silicon Laboratories in a report on Tuesday, December 17th. They set a "neutral" rating and a $130.00 price target for the company. StockNews.com downgraded Silicon Laboratories from a "hold" rating to a "sell" rating in a research note on Friday. Benchmark raised shares of Silicon Laboratories from a "hold" rating to a "buy" rating and set a $160.00 target price on the stock in a research report on Wednesday, February 5th. Morgan Stanley dropped their target price on shares of Silicon Laboratories from $123.00 to $97.00 and set an "equal weight" rating on the stock in a research report on Tuesday, November 5th. Finally, Stifel Nicolaus lifted their price target on shares of Silicon Laboratories from $135.00 to $145.00 and gave the stock a "buy" rating in a report on Monday, January 6th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and six have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $136.20.

Silicon Laboratories Stock Performance

Silicon Laboratories stock traded down $0.90 during mid-day trading on Friday, reaching $149.54. The company's stock had a trading volume of 266,274 shares, compared to its average volume of 366,366. Silicon Laboratories Inc. has a 12-month low of $94.00 and a 12-month high of $154.91. The company has a market capitalization of $4.85 billion, a P/E ratio of -25.18 and a beta of 1.16. The firm's fifty day moving average price is $133.35 and its two-hundred day moving average price is $118.22.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last released its quarterly earnings results on Tuesday, February 4th. The semiconductor company reported ($0.11) earnings per share for the quarter, hitting the consensus estimate of ($0.11). The firm had revenue of $166.25 million for the quarter, compared to analysts' expectations of $166.09 million. Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. The business's quarterly revenue was up 91.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($1.19) earnings per share. On average, research analysts predict that Silicon Laboratories Inc. will post -0.47 EPS for the current fiscal year.

Insider Transactions at Silicon Laboratories

In related news, Director William G. Bock sold 2,000 shares of the stock in a transaction on Wednesday, January 22nd. The stock was sold at an average price of $140.77, for a total value of $281,540.00. Following the transaction, the director now owns 32,115 shares of the company's stock, valued at $4,520,828.55. This represents a 5.86 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Navdeep S. Sooch sold 2,360 shares of the stock in a transaction on Wednesday, February 5th. The shares were sold at an average price of $149.00, for a total value of $351,640.00. Following the completion of the transaction, the director now directly owns 400,567 shares in the company, valued at approximately $59,684,483. This represents a 0.59 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.72% of the company's stock.

About Silicon Laboratories

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.